FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 305 participants.
Also called NCT02652806
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 305 participants
- Sponsor
- Registry
-
NCT02652806
-
- Other papers using this trial's data
- Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02652806. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2017-01-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease
- Condition
- Anemia
- Intervention (Drug)
- FG-4592
- Intervention (Drug)
- Epoetin Alfa
- Lead sponsor
- Kyntra Bio
Record details
- Record id
cardio:ct-nct02652806- Content hash
3f18296202e414b3bc5f3b844b464fb76852fb3d5573a458cdc4ea873b3dc2fb